<sup>225</sup>Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins
Actinium-225 and other alpha-particle-emitting radionuclides have shown high potential for cancer treatment. Reconstituted high-density lipoproteins (rHDL) specifically recognize the scavenger receptor B type I (SR-BI) overexpressed in several types of cancer cells. Furthermore, after rHDL-SR-BI rec...
Main Authors: | Tania Hernández-Jiménez, Guillermina Ferro-Flores, Enrique Morales-Ávila, Keila Isaac-Olivé, Blanca Ocampo-García, Liliana Aranda-Lara, Clara Santos-Cuevas, Myrna Luna-Gutiérrez, Laura De Nardo, Antonio Rosato, Laura Meléndez-Alafort |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/7/2156 |
Similar Items
-
α-Zirconium(IV) Phosphate: Static Study of <sup>225</sup>Ac Sorption in an Acidic Environment and Its Kinetic Sorption Study Using <sup>nat</sup>Eu as a Model System for <sup>225</sup>Ac
by: Lukáš Ondrák, et al.
Published: (2023-08-01) -
<sup>225</sup>Ac-iPSMA-RGD for Alpha-Therapy Dual Targeting of Stromal/Tumor Cell PSMA and Integrins
by: Blanca Ocampo-García, et al.
Published: (2023-11-01) -
Synthesis and Evaluation of <sup>177</sup>Lu-DOTA-PD-L1-i and <sup>225</sup>Ac-HEHA-PD-L1-i as Potential Radiopharmaceuticals for Tumor Microenvironment-Targeted Radiotherapy
by: Myrna Luna-Gutiérrez, et al.
Published: (2023-08-01) -
Ac-EAZY! Towards GMP-Compliant Module Syntheses of <sup>225</sup>Ac-Labeled Peptides for Clinical Application
by: Marc Pretze, et al.
Published: (2021-07-01) -
[<sup>225</sup>Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer: Preclinical Evaluation and Comparison with [<sup>225</sup>Ac]Ac-PSMA-617
by: Sarah D. Busslinger, et al.
Published: (2022-11-01)